《藍籌業績》蒙牛乳業(02319.HK)中期純利37.51億人民幣增27.3% 不派息
蒙牛乳業(02319.HK)公布6月止六個月中期業績,收入477.22億人民幣(下同),按年增加4%。錄得純利37.51億元,增長27.3%,每股盈利94.9分。不派中期息。
上半年,毛利174.59億元,微降0.5%,毛利率下降1.6個百分點至36.6%,主要由於原輔材料平均價格上漲,以及增加廠房及生產設備投產所產生的折舊費用增加。
期內,特侖蘇和蒙牛純牛奶及每日鮮語鮮牛奶保持強勁增長、低溫業務持續佔據領先地位並獲取市場份額,集團液態奶業務收入增至396.65億元。冰淇淋銷售實現跑贏行業的快速增長,收入同上升29.9%至39.04億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.